Herpes simplex virus resistance to antiviral drugs

Journal of Clinical Virology

Volumn 26, Issue 1, 2003, Pages 29-37

  Morfin, Florence ^a   Thouvenot, Danielle ^a  

^a HOSPICES CIVILS DE LYON   (France)

Author keywords

DNA polymerase; Herpes simplex virus; Resistance; Thymidine kinase

Indexed keywords

ACICLOVIR; CIDOFOVIR; DNA POLYMERASE; FAMCICLOVIR; FOSCARNET; PENCICLOVIR; THYMIDINE KINASE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC RESISTANCE; CODON; CROSS RESISTANCE; DNA POLYMORPHISM; GENE DELETION; GENE FUNCTION; GENE INSERTION; GENE MUTATION; GENETIC ANALYSIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS RESISTANCE;

ACYCLOVIR; ANTIVIRAL AGENTS; CYTOSINE; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, MULTIPLE, VIRAL; DRUG RESISTANCE, VIRAL; ENZYME INHIBITORS; EXODEOXYRIBONUCLEASES; FOSCARNET; HERPES SIMPLEX; HUMANS; IMMUNOCOMPROMISED HOST; MUTATION; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; SIMPLEXVIRUS; THYMIDINE KINASE; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0037264227     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(02)00263-9     Document Type: Review

References (53)

1. Andrei G., Snoeck R., DeClercq E., Esnouf R., Fiten P., Opdenakker G. Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene. J. Gen. Virol. 81:2000;639-648.
2. Balasubramaniam N.K., Veerisetty V., Gentry G.A. Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary-structure predictions and conservation. J. Gen. Virol. 71:1990;2979-2987.
3. Bestman-Smith J., Schmit I., Papadopoulou B., Boivin G. Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues. J. Virol. 75:2001;3105-3110.
4. Blot N., Schneider P., Young P., Janvresse C., Dehesdin D., Tron P., Vannier J.P. Treatment of acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant. Bone Marrow Transplant. 26:2000;903-905.
5. Bodaghi B., Mougin C., Michelson S., Agut H., Dighiero P., Offret H., Frau E. Acyclovir-resistant bilateral keratitis associated with mutations in the HSV-1 thymidine kinase gene. Exp. Eye Res. 71:2000;353-359.
6. Boon R.J., Bacon T.H., Robey H.L., Coleman T.J., Connolly A., Crosson P., Sacks S.L. Antiviral susceptibilities of herpes simplex virus from immuncompetent subjects with recurrent herpes labialis: a UK-based survey. J. Antimicrob. Chemother. 46:2000;324-325.
7. Boucher A, Morfin F, Souillet G, Aymard M, Thouvenot D. Genetic characterization of 12 sequential HSV-1 isolates from a bone marrow transplant recipient who developed acyclovir and foscarnet resistant infection (poster #769). 40th ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), Toronto, Canada, September 2000.
8. Boyd M.R., Safrin S., Kern E.R. Penciclovir: a review of its spectrum of activity, selectivity, and cross-resistance pattern. Antiviral Chem. Chemother. 4:(suppl. 1):1993;3-11.
9. Burns WH, Saral R, Santos GW, Laskin OL, Leitman PS, McLaren C, Barry DW. Isolation and characterization of resistant herpes simplex virus after acyclovir therapy. Lancet 1982 Feb 20;1(8269):421-3.
10. Chatis P.A., Crumpacker C.S. Analysis of the thymidine kinase gene from clinically isolated acyclovir-resistant herpes simplex virus. Virology. 180:1991;793-797.
11. Chiba A., Suzutani T., Saijo M., Koyano S., Azuma M. Analysis of nucleotide sequence variations in herpes simplex virus type 1 and 2, and varicella-zoster virus. Acta Virol. 42:1998;401-407.
12. Chiou H.C., Kumura K., Hu A., Kerns K.M., Coen D.M. Penciclovir-resistance mutations in the herpes simplex virus DNA polymerase gene. Antiviral Chem. Chemother. 6:1995;281-288.
13. Christophers J., Clayton J., Craske J., Ward R., Collins P., Trowbridge M., Darby G. Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob. Agents Chemother. 42:1998;868-872.
14. Coen D.M., Kosz-Vnenchak M., Jacobson J.G., et al. Thymidine-kinase negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. USA. 86:1989;4736-4740.
15. Collins P., Oliver N.M. Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir. J. Antimicrob. Chem. 18:(suppl. B):1986;103-112.
16. Collins P., Larder B.A., Oliver N.M., Kemp S., Smith I.W., Darby G. Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. J. Gen. Virol. 70:1989;375-382.
17. Crumpacker C.S., Schnipper L.E., Marlowe S.I., Kowalsky P.N., Hershey B.J., Levin M.J. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. New Engl. J. Med. 306:1982;343-346.
18. Danve C., Morfin F., Thouvenot D., Aymard M. A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus to acyclovir. J. Virol. Meth. 105:2002;207-217.
19. Darby G., Larder B.A., Inglis M.M. Evidence that the active center' of the Herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. J. Gen. Virol. 67:1986;753-758.
20. De Clercq E., Naessens L., De Bolle L., Schols D., Zhang Y., Neyts J. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev. Med. Virol. 11:2001;381-395.
21. Efstathiou S., Kemp S., Darby G., Minson A.C. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J. Gen. Virol. 70:1989;869-879.
22. Elion G.B. Acyclovir: discovery, mechanism of action and selectivity. J. Med. Virol. S1:1993;2-6.
23. Englund J.A., Zimmerman M.E., Swierkosz E.M., et al. Herpes simplex virus resistant to acyclovir: a study in a tertiary care center. Ann. Intern. Med. 112:1990;416-422.
24. Fife K.H., Crumpacker C.S., Mertz G.J., Hill E.L., Boone G.S. Recurrence and resistance patterns of HSV following cessation of > 6 years of chronic suppression with acyclovir. J. Infect. Dis. 169:1994;1338-1341.
25. Gaudreau A., Hill E., Balfour H.H., Erice A., Boivin G. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex virus from immunocompromised patients. J. Infect. Dis. 178:1998;297-303.
26. Gibbs J.S., Chiou H.C., Bastow K.F., Cheng Y.C., Coen D.M. Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition. Proc. Natl. Acad. Sci. USA. 85:1988;6672-6676.
27. Hill E.L., Hunter G.A., Ellis M.N. In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 35:1991;2322-2328.
28. Hwang C.B.C., Horsburgh B., Pelosi E., Roberts S., Digard P., Coen D.M. A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc. Natl. Acad. Sci. USA. 91:1994;5461-5465.
29. Kit S., Sheppard M., Ichimura H., Nusinoff-Lehrman S., Ellis M.N., Fyfe J.A., Otsuka H. Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir. Antimicrob. Agents Chemother. 31:1987;1483-1490.
30. Kost R.G., Hill E.L., Tigges M., Straus S.E. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. New Engl. J. Med. 329:1993;1777-1782.
31. Kudo E., Shiota H., Naito T., Satake K., Itakura M. Polymorphisms of thymidine kinase gene in herpes simplex virus type 1: analysis of clinical isolates from herpetic keratitis patients and laboratory strains. J. Med. Virol. 56:1998;151-158.
32. Langlois M., Allard J.P., Nugier F., Aymard M. A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs. J. Biol. Stand. 14:1986;201-211.
33. Larder B.A., Cheng Y.-C., Darby G. Characterization of abnormal thymidine kinases induced by drug-resistant strains of herpes simplex virus type 1. J. Gen. Virol. 64:1983;523-532.
34. Larder B.A., Kemp S.D., Darby G. Related functional domains in virus DNA polymerases. EMBO J. 6:1987;169-175.
35. Lee N.Y., Tang Y.W., Espy M.J., Kolbert C.P., Rys P.N., Mitchell P.S., Day S.P., Henry S.L., Persing D.H., Smith T.F. Role of genotypic analysis of the thymidine kinase gene of herpes simplex virus for determination of neurovirulence and resistance to acyclovir. J. Clin. Microb. 37:1999;3171-3174.
36. McKnight S.L. The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene. Nucleic Acids Res. 8:1980;5949-5964.
37. Morfin F, Bilger K, Najioullah F, Boucher A, Thiebaut A, Raus N, Bosshard S, Aymard M, Michallet M, Thouvenot D. HSV infection after bone marrow transplantation: a 4-year survey, submitted.
38. Morfin F., Thouvenot D., Aymard M., Souillet G. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harboring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene. J. Med. Virol. 62:2000;247-250.
39. Morfin F., Souillet G., Bilger K., Ooka T., Aymard M., Thouvenot D. Genetic characterization of the thymidine kinase from acyclovir-resistant and acyclovir-susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients. J. Infect. Dis. 182:2000;290-293.
40. Mouly F., Baccard M., Scieux C., Schneil L., Locq-Ebner S., Morinet F., Morel P. Chronic recurrent acyclovir-resistant genital herpes in an immunocompetent patient. Dermatology. 190:1995;177.
41. Nugier F., Collins P., Larder B.A., Langlois M., Aymard M., Darby G. Herpes simplex virus isolates from an immunocompromised patient who failed to respond to acyclovir treatment express thymidine kinase with altered substrate specificity. Antiviral Chem. Chemother. 2:1991;295-302.
42. Nugier F., Colin J.N., Aymard M., Langlois M. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a 2-year sensitivity screening survey. J. Med. Virol. 36:1992;1-12.
43. Oram R.J., Marcellino D., Strauss D., Gustafson E., Talarico C.L., Root A.K., Sharma P.L., Thompson K., Fingeroth J.D., Crumpacker C., Herold B.C. Characterization of an acyclovir-resistant herpes simplex virus type 2 strains isolated from a premature neonate. J. Infect. Dis. 181:2000;1458-1461.
44. Palù G., Gerna G., Bevilacqua F., Marcello A. A point mutation in the thymidine kinase gene is responsible for acyclovir resistance in herpes simplex virus type 2 sequential isolates. Virus Res. 25:1992;133-144.
45. Rechtin T.M., Black M.E., Mao F., Lewis M.L., Drake R.R. Purification and photoaffinity labeling of herpes simplex virus type-1 thymidine kinase. J. Bio. Chem. 270:1995;7055-7060.
46. Safrin S., Crumpacker C., Chatis P., Davis R., Hafner R., Rush J., Kessler H.A., Landry B., Mills J., et al. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. New Engl. J. Med. 325:1991;551-555.
47. Safrin S., Elbeik T., Mills J. A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates. J. Infect. Dis. 169:1994;879-882.
48. Schmit I., Boivin G. Characterization of the DNA polymerase and thymidine kinase genes of herpes simplex virus isolates from AIDS patients in whom acyclovir and foscarnet therapy sequentially failed. J. Infect. Dis. 180:1999;487-490.
49. Sibrack C.D., Gutman L.T., Wilfert C.M., McLaren C., St Clair M.H., Keller P.M., Barry D.W. Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child. J. Infect. Dis. 146:1982;673-682.
50. Straus S.E., Takiff H.E., Seidlin M., Bachrach S., Lininger L., Digiovanna J.J., et al. Suppression of frequently recurring genital herpes: a placebo-controlled double-blind trial of oral acyclovir. New Engl. J. Med. 310:1984;1545-1550.
51. Swierkosz E.M., Scholl D.R., Brown J.L., Jollick J.D., Gleaves C.A. Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus. Antimicrob. Agents Chemother. 31:1987;1465-1469.
52. Venard V., Dauendorffer J.N., Carret A.S., Corsaro D., Edert D., Bordigoni P., Le Faou A. Investigation of acyclovir-resistant herpes simplex virus I infection in a bone marrow transplantation unit: genotyping shows that different strains are involved. J. Hosp. Infect. 47:2001;181-187.
53. Wong S.W., Wahl A.F., Yuan P.M., Arai N., Pearson B.E., Arai K., Korn D., Hunkapiller M.W., Wang T.S. Human DNA polymerase alpha gene expression is cell proliferation dependent and its primary structure is similar to both prokaryotic and eukaryotic replicative DNA polymerases. EMBO J. 7:1988;37-47.